Languages:

Educational Course on Treating GvHD

4 - 5 June 2024

University Medical Center (UKE) and University Heart Center (UHZ), Hamburg, Germany

View Centre

The Goal

The goal of the GvHD Interactive Course is to leverage knowledge on the positioning of biomarkers and provide latest trends on the use of combination therapies in the treatment of GvHD and foster discussion between peers.

Agenda

Download Agenda PDF

Day 1 - 4 June 2024

Arrival of participants

 

20.00 – 20.15
Meeting at hotel lobby

 

20.15
Dinner with the faculty

Day 2 - 5 June 2024

09.30 – 09.45
Welcome and introduction - Prof Francis Ayuk

 

09.45 – 10.30
Acute GvHD - Prof Francis Ayuk

• Pathophysiology
• Classification and grading

 

10.30 – 10.45
Coffee break

 

10.45 – 12.00
Acute GvHD - Prof Francis Ayuk

• Biomarkers
• Patient selection for ECP
• Combination therapy

 

12.00 – 12.10
Interactive discussion

 

12.10 – 13.10
Chronic GvHD - Prof Daniel Wolff

• Pathophysiology
• Classification and grading
• Biomarkers
• Patient selection for ECP
• Impact and measurement of late effects
• Organ specificity

 

13.10 – 14.10
Lunch

 

14.10 – 15.10
Patient cases discussion - All

 

15.10 – 15.20
Final remarks and close


GvHD: Graft versus Host Disease, ECP: Extracorporeal Photopheresis

 

For this course, participants are required to submit one patient case for discussion 15 days in
advance of the session

 

All speakers are subject to contract.
This is a commercial programme run by Therakos (UK) Ltd, part of Mallinckrodt Pharmaceuticals
This information is not intended for healthcare professionals based in the US and Canada.

Hosted by

Prof Francis Ayuk University Medical Center Hamburg-Eppendorf
Prof Francis Ayuk

Deputy Director, Clinic for Stem Cell Transplantation, University Medical Center Hamburg, Germany

Brought to you by the Therakos Institute

This is a commercial programme run by Therakos (UK) Ltd, part of Mallinckrodt Pharmaceuticals